Gelatin
( DrugBank: Gelatin / KEGG DRUG: Gelatin )
7 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 28 | Systemic amyloidosis | 8 |
| 47 | Buerger disease | 2 |
| 62 | Paroxysmal nocturnal hemoglobinuria | 1 |
| 70 | Spinal stenosis | 3 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 71 | Idiopathic osteonecrosis of the femoral head | 2 |
| 97 | Ulcerative colitis | 3 |
| 269 | Pyogenic arthritis | 2 |
28. Systemic amyloidosis
Clinical trials : 454 / Drugs : 430 - (DrugBank : 90) / Drug target genes : 66 - Drug target pathways : 183
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
47. Buerger disease
Clinical trials : 21 / Drugs : 26 - (DrugBank : 14) / Drug target genes : 7 - Drug target pathways : 19
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
62. Paroxysmal nocturnal hemoglobinuria
Clinical trials : 380 / Drugs : 240 - (DrugBank : 38) / Drug target genes : 28 - Drug target pathways : 122
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
70. Spinal stenosis
Clinical trials : 146 / Drugs : 244 - (DrugBank : 71) / Drug target genes : 96 - Drug target pathways : 110
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
71. Idiopathic osteonecrosis of the femoral head
Clinical trials : 45 / Drugs : 49 - (DrugBank : 23) / Drug target genes : 15 - Drug target pathways : 40
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
97. Ulcerative colitis
Clinical trials : 3,566 / Drugs : 2,369 - (DrugBank : 339) / Drug target genes : 210 - Drug target pathways : 245
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
269. Pyogenic arthritis
Clinical trials : 35 / Drugs : 44 - (DrugBank : 17) / Drug target genes : 12 - Drug target pathways : 91
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|